341 related articles for article (PubMed ID: 2493715)
21. Treatment of the anaemia of end-stage renal disease with recombinant human erythropoietin.
Verbeelen D; Hauglustaine D; Sennesael J
Neth J Med; 1988 Aug; 33(1-2):60-7. PubMed ID: 3247012
[No Abstract] [Full Text] [Related]
22. [Treatment of anemia in children undergoing chronic hemodialysis with recombinant human erythropoietin].
Rendo P; Biscigniano L; Turconi A; Sánchez Avalos JC; Greco J
Medicina (B Aires); 1994; 54(5 Pt 1):392-8. PubMed ID: 7658972
[TBL] [Abstract][Full Text] [Related]
23. [The efficacy of an erythropoietin-calcitriol combination in patients with chronic kidney failure on programmed hemodialysis].
Nikolaev AIu; Klepikov PV; Lashutin SV; Kukhtevich AV
Ter Arkh; 1995; 67(5):27-31. PubMed ID: 7638771
[TBL] [Abstract][Full Text] [Related]
24. [Status epilepticus in chronically dialyzed patients treated with erythropoietin].
Massetani R; Galli R; Calabrese R; Sartucci F; Rindi P; Severino Brandi L; Murri L
Riv Neurol; 1991; 61(6):215-8. PubMed ID: 1813973
[TBL] [Abstract][Full Text] [Related]
25. The continuous erythropoietin receptor activator (C.E.R.A.) corrects anemia at extended administration intervals in patients with chronic kidney disease not on dialysis: results of a phase II study.
Provenzano R; Besarab A; Macdougall IC; Ellison DH; Maxwell AP; Sulowicz W; Klinger M; Rutkowski B; Correa-Rotter R; Dougherty FC;
Clin Nephrol; 2007 May; 67(5):306-17. PubMed ID: 17542340
[TBL] [Abstract][Full Text] [Related]
26. Side effects of erythropoietin therapy.
Bennett WM
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):84-6. PubMed ID: 1928085
[TBL] [Abstract][Full Text] [Related]
27. [Erythropoietin--the first hematologic hormone in clinical use].
Rhyner K
Schweiz Med Wochenschr; 1988 Mar; 118(11):375-80. PubMed ID: 3287601
[TBL] [Abstract][Full Text] [Related]
28. The anemia of chronic renal failure: pathophysiology and effects of recombinant erythropoietin.
Eschbach JW; Haley NR; Adamson JW
Contrib Nephrol; 1990; 78():24-36; discussion 37. PubMed ID: 2225841
[No Abstract] [Full Text] [Related]
29. Effects of erythropoietin on strength and functional status of patients on hemodialysis.
Guthrie M; Cardenas D; Eschbach JW; Haley NR; Robertson HT; Evans RW
Clin Nephrol; 1993 Feb; 39(2):97-102. PubMed ID: 8448925
[TBL] [Abstract][Full Text] [Related]
30. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
Hussein MM; Mooij JM; Roujouleh H
Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
[No Abstract] [Full Text] [Related]
31. [Chronic kidney failure, anemia and erythropoietin].
Sulková S
Cas Lek Cesk; 1990 May; 129(18):545-9. PubMed ID: 2350772
[TBL] [Abstract][Full Text] [Related]
32. [Erythropoietin treatment of dialysis patients].
Stenver DI; Nielsen B
Ugeskr Laeger; 1994 Apr; 156(17):2589-91. PubMed ID: 8016967
[TBL] [Abstract][Full Text] [Related]
33. Erythropoietin: a therapeutic tool.
Agarwal MB
J Assoc Physicians India; 1992 Jan; 40(1):9-10. PubMed ID: 1634473
[No Abstract] [Full Text] [Related]
34. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Results of a multicenter trial in patients with end-stage renal disease.
Kühn K; Nonnast-Daniel B; Grützmacher P; Grüner J; Pfåffl W; Baldamus CA; Scigalla P
Contrib Nephrol; 1988; 66():94-103. PubMed ID: 3292152
[No Abstract] [Full Text] [Related]
35. Erythropoietin use in pregnancy: two cases and a review of the literature.
Scott LL; Ramin SM; Richey M; Hanson J; Gilstrap LC
Am J Perinatol; 1995 Jan; 12(1):22-4. PubMed ID: 7710570
[TBL] [Abstract][Full Text] [Related]
36. Who should receive recombinant human erythropoietin?
Van Stone JC
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):3-7. PubMed ID: 2669084
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human erythropoietin (rHuEPO) in the treatment of anaemia of chronic renal failure.
Desai JD; Shah BV
J Assoc Physicians India; 1991 Jun; 39(6):483-5. PubMed ID: 1938855
[No Abstract] [Full Text] [Related]
38. Erythropoietin.
Beresford CH
N Z Med J; 1989 Apr; 102(866):185-6. PubMed ID: 2652007
[No Abstract] [Full Text] [Related]
39. Management of blood pressure changes during recombinant human erythropoietin therapy.
Levin N
Semin Nephrol; 1989 Mar; 9(1 Suppl 2):16-20. PubMed ID: 2669081
[TBL] [Abstract][Full Text] [Related]
40. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
Mohini R
Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
